12 completed. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 12 |
Follow Renal Failure: new trials by email Literature Review of Renal Failure trials Research Report on Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Desflurane vs. Sevoflurane in Endovascular Aortic Repair Sevoflurane, Desflurane - Renal Failure | Phase 4 | Completed | Begoña Quintana Villamandos | 80 | 2017-09-20 | 2023-11-21 |
| Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant elbasvir (50mg) / grazoprevir (100mg) (fixed dose combination) - Renal Failure | Phase 4 | Completed | Massachusetts General Hospital | 8 | 2017-02-01 | 2020-06-09 |
| The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas GTN patch, placebo comparator - Renal Failure | Phase 4 | Completed | University Hospital Birmingham | 200 | 2013-04-01 | 2015-06-02 |
| Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis a pre-heparin-coated hemodialysis filter; Hepran - Renal Failure | Phase 4 | Completed | Oslo University Hospital | 12 | 2011-09-01 | 2016-02-04 |
| The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition double-chamber bag Stay-Safe Balance system, glucose-based dialysis solution - Renal Failure, ESRD | Phase 4 | Completed | Chinese University of Hong Kong | 68 | 2010-09-01 | 2014-09-08 |
| Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation albumin, Midodrine, Placebo - Renal Failure, Hyponatremia | Phase 4 | Completed | Hospital Clinic of Barcelona | 199 | 2008-08-01 | 2016-08-18 |
| The Vienna Prograf and Endothelial Progenitor Cell Extension Study Tacrolimus - Immunosuppression, Renal Failure | Phase 4 | Completed | Medical University of Vienna | 87 | 2008-03-01 | 2018-11-23 |
| Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome dose adaptation of Enoxaparin, normal injection of Enoxaparine - Acute Coronary Syndrome, Renal Failure | Phase 4 | Completed | French Cardiology Society | 67 | 2006-12-01 | 2011-07-21 |
| Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism Hectorol (doxercalciferol capsules), 0.5mcg - Secondary Hyperparathyroidism, Renal Failure | Phase 4 | Completed | Genzyme, a Sanofi Company | 70 | 2005-07-01 | 2015-05-05 |
| Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy Effects of doxazosin on morning surge in diabetic patients - Diabetes Mellitus, Essential Hypertension | Phase 4 | Completed | Yokohama City University Medical Center | 98 | 2004-01-01 | 2007-05-10 |
| Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation Cyclosporine discontinuation, Rapamycin medication - Heart Transplantation, Renal Failure | Phase 4 | Completed | Heidelberg University | 40 | 2003-10-01 | 2005-08-02 |
| Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy Acetylcysteine, Theophylline, Placebo - Contrast Induced Nephropathy, Kidney Diseases | Phase 4 | Completed | Technical University of Munich | 254 | 2002-02-01 | 2007-06-27 |
Renal Insufficiency (12) · Acute Coronary Syndrome (1) · Arteriovenous Fistula (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Diabetic Nephropathies (1) · Essential Hypertension (1) · Fibrosis (1) · Gastrointestinal Hemorrhage (1) · Hepatic Encephalopathy (1) · Hyperparathyroidism, Secondary (1) · Hyponatremia (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Malnutrition (1)
Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Male Urogenital Diseases (12) · Urogenital Diseases (12) · Urologic Diseases (12) · Kidney Diseases (11) · Cardiovascular Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Vascular Diseases (4) · Nutritional and Metabolic Diseases (3) · Pathologic Processes (3) · Chronic Disease (2) · Disease Attributes (2) · Endocrine System Diseases (2) · Metabolic Diseases (2)
1 alpha-hydroxyergocalciferol (1) · Acetylcysteine (1) · Albumins (1) · Desflurane (1) · Midodrine (1) · Sevoflurane (1) · Tacrolimus (1) · Theophylline (1) · elbasvir (1) · elbasvir-grazoprevir drug combination (1) · grazoprevir (1)
Begoña Quintana Villamandos (1) · Chinese University of Hong Kong (1) · French Cardiology Society (1) · Genzyme, a Sanofi Company (1) · Heidelberg University (1) · Hospital Clinic of Barcelona (1) · Massachusetts General Hospital (1) · Medical University of Vienna (1) · Oslo University Hospital (1) · Technical University of Munich (1) · University Hospital Birmingham (1) · Yokohama City University Medical Center (1)
Germany (2) · Spain (2) · United States (2) · France (1) · Hong Kong (1) · Japan (1) · Norway (1) · Puerto Rico (1) · United Kingdom (1)
Cheuk Chun Szeto, MD (1) · Gen Yasuda, MD (1) · Gere Sunder-Plassmann, MD (1) · Nicholas G Inston, FRCS (1) · Philip KT Li, MD (1) · Raymond Chung, MD (1) · Thomas J Dengler, MD (1) · Wolfgang Huber, MD (1)
PMID 24866870, PMID 26510186, PMID 27470183, PMID 30138685, PMID 31266056, PMID 41079741